HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. Opioid and Pain Management - understanding, management, diagnosis and treatment information Cholesterol - This knowledge centre contains a comprehensive coverage of cholesterol related information, cardivascular disease management guidelines and treatment options.

Arthritis

Please note - this EPG Arthritis Knowledge Centre is for Doctors and other Healthcare Professionals. Enter the Arthritis Knowledge Centre.

Arthritis is a complex disorder that comprises more than 100 distinct musculoskeletal conditions and can affect people at any stage of life. Arthritis causes joint pain, loss of movement, and inflammation. Arthritis Knowledge Centre

Common forms of arthritis include osteoarthritis (OA) and rheumatoid arthritis. Both OA and RA are chronic and incurable but respond well to intervention.Osteoarthritis is the most common type of arthritis.

The prevalence increases with age, and most people over 60 years will have some radiological evidence of it. Osteoarthritis is the result of active, sometimes inflammatory but potentially reparative processes rather than the inevitable result of trauma and ageing.Rheumatoid arthritis is a chronic symmetrical polyarthritis of unexplained cause.

It is a systematic disorder characterized by chronic inflammatory synovitis of mainly peripheral joints. Its course is extremely variable and it is associated with nonarticular features.

To diagnose arthritis, there are a number of guidelines which outline the classification criteria, as well as tools to assess the patients pain.

There are a variety of treatment options available to help manage the pain and inflammation of osteo and rheumatoid arthritis, both pharmacological and non-pharmacological. It is important to balance the potential benefit against the potential side-effects.

Enter the Arthritis Knowledge Centre

What’s in the Knowledge Centre?

More Results Drugs Relating To arthritis
  • Enbrel 25 mg powder and solvent for solution for injection
    ... arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. Enbrel has not been studied in children aged less than 2 years.   Psoriatic arthritis Treatment of active and progressive psoriatic arthritis in ...
  • HUMIRA 40 mg
    Rheumatoid arthritis : Humira in combination with methotrexate, is indicated for: § the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. § the treatment of ...
  • ECONAC
    ... in a wide range of conditions, including: arthritic conditions such as rheumatoid arthritis , osteo-arthritis , ankylosing spondylitis, acute gout; acute musculoskeletal disorders such as peri-arthritis (eg, frozen shoulder), tendinitis, tenosynovitis, bursitis; other painful conditions resulting ...
  • Simponi 50 mg solution for injection
    Rheumatoid arthritis (RA) Simponi, in combination with methotrexate (MTX), is indicated for the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response to disease modifying anti rheumatic drug (DMARD) therapy including MTX has been inadequate. Simponi has ...
  • Metoject 50 mg/ml solution for injection
    Metoject 50 mg/ml is indicated for the treatment of ? active rheumatoid arthritis in adult patients, ? polyarthritic forms of severe, active juvenile idiopathic arthritis, when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate, ? severe recalcitrant disabling ...
  • NEORAL
    ... in whom conventional therapy is ineffective or inappropriate. Rheumatoid arthritis NEORAL Soft Gelatin Capsules and NEORAL Oral Solution are indicated for the treatment of severe, active rheumatoid arthritis in patients in whom classical, slow-acting antirheumatic agents are inappropriate or ...

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES